Effect of Angeliq on Blood Pressure (BP) in Postmenopausal Hypertensive Women
Completed
Bayer
Phase 3
2004-04-01
The objective of the study is to evaluate the effects of Angeliq on BP over a period of 8
weeks in postmenopausal women who may benefit from hormone replacement therapy (HRT) for the
relief of vasomotor symptoms and who have hypertension.
A Clinical Study on Yasmin® vs. Marvelon® in Chinese Women Requiring Contraception
Completed
Bayer
Phase 3
2003-11-01
The purpose of this study is to evaluate the effectiveness in terms of prevention of
pregnancy and safety of the oral contraceptive Yasmin and Marvelon on cycle control in
healthy Chinese women
EURAS is a multi-national, controlled, prospective, post-marketing, non-intervention cohort
study of new users of drospirenone/ethinylestradiol (DRSP/EE),
levonorgestrel/ethinylestradiol (LNG/EE) and other oral contraceptives (OCs) under routine
conditions of medical practice in seven European countries. Baseline survey and semiannual,
active follow-up are based on postal questionnaires, with validation of reported events by
the women's treating physicians. A multifaceted 4-level follow-up procedure will be
established to ensure low loss to follow-up rates. The objective of the study is the
investigation of the incidence of rare serious adverse events associated with the use of new
and established OCs, and specifically the incidence of thromboembolic events.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
